Dr Andrew Stokes

Dr. Andrew Stokes is a Clinical Research Physician specializing in global rare diseases at Chiesi UK, focusing on Fabry Disease clinical development with experience in Phase 2/3 trials. Currently serving as PMST Associate ST4 with the Faculty of Pharmaceutical Medicine and as a Medical Doctor for the General Medical Council, Dr. Stokes has previously held key roles such as Sub-Investigator and Senior Physician at Re:Cognition Health, where involvement included studies on various forms of dementia. As Associate Medical Director at Richmond Pharmacology, responsibilities included study design, protocol review, and management of research teams. Dr. Stokes has a broad medical background with experience in oncology and COVID-19 response at Royal Free London NHS Foundation Trust, alongside extensive training in pharmaceuticals and neuroscience, including a scholarship-funded education at Trinity College Dublin.